« Return to News | CROs/Service Providers

AMRI, Ono Pharma broaden Smartsourcing collaboration

Monday, April 29, 2013 11:21 AM

AMRI, a global contract research and manufacturing organization, has entered into a new five-year service agreement with Ono Pharmaceutical, a pharmaceutical company based in Osaka, Japan

AMRI may provide Ono a range of services from early drug discovery to cGMP manufacturing. The two companies have already agreed to medicinal chemistry projects within the new framework to collaborate on additional hit-to-lead and lead optimization for two new molecules, with the work to take place at AMRI's medicinal chemistry laboratories in Albany, N.Y.

An early adopter of the AMRI Smartsourcing concept, Ono has been utilizing AMRI's integrated global facilities and capabilities for projects ranging from early drug discovery, including high-throughput screening (HTS), biology support and computer-aided drug discovery (CADD), to multiple medicinal chemistry programs and a variety of drug development and cGMP programs.

"Smartsourcing is an industry leading movement to strategic decision making and the true measurement of results and success in drug discovery, development and manufacturing,” said Louis Garguilo, vice president of business development. “Over the years, our relationship with Ono has grown based on this type of value-added collaboration. We are also happy to announce this expanding relationship in conjunction with the 2013 Biotechnology Industry Organization (BIO) International Convention in Chicago, at the one-year anniversary of our re-branding launch of AMRI Smartsourcing at this very show last year in Boston."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.